Natera

Youtube Subscribe

Open: 70.03 Close: 71.15 Change: 1.12

What an AI found about Natera after reading the whole Internet.

This document will help you to evaluate Natera without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Natera are: Natera, Price, Day, High, Week, Low, global, and the …

Concept Map

Semantic Network

Stock Summary

Natera, Inc. develops and commercializes molecular testing services worldwide. Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies, is a non invasive prenatal.

Today's Summary

Natera, Inc.: NASDAQ:NTRA Last Price 69.76 Change -0.92% Day High 70.96 52 Week High 71.29 Day Low 69.14 52 Week Low 36.90 Todays Open 70.41 Previous Close 70.42.

Today's News

Natera, Inc.: NASDAQ:NTRA Last Price 69.76 Change -0.92% Day High 70.96 52 Week High 71.29 Day Low 69.14 52 Week Low 36.90 Todays Open 70.41 Previous Close 70. 41. Explore the variety of open remote roles at Natera, offering flexible work options across multiple disciplines and skill levels. Find your next opportunity by exploring profiles of companies that are similar to NaterA. The Race to the Top: Exploring the Pitfalls of Fast Success. The Importance of slow and diligent success versus rushed achievements in the culinary field. The global Non-invasive Prenatal Genetic Testing market size was valued at USD million in 2023 and is expected to expand at a CAGR of Percent during the forecast period, reaching USD million by 2032. Natera is a global leader in cell-free DNA (cfDNA) testing. Analyzing Analyst Ratings: A Detailed Breakdown An in-depth analysis of recent analyst actions unveils how financial experts perceive Natera. Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Nateras future value.

Stock Profile

"Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. Its products include Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus, as well as in twin pregnancies; Horizon carrier screening test for individuals and couples determine if they are carriers of genetic variations that cause certain genetic conditions; Vistara single-gene NIPT screens for 25 single-gene disorders that cause severe skeletal, cardiac, and neurological conditions; Spectrum, preimplantation genetic tests for couples undergoing IVF; Anora that analyzes miscarriage tissue from women; Empower, a hereditary cancer screening test; and non-invasive prenatal paternity product, which allows a couple to establish paternity without waiting for the child to be born. The company's products also comprise Signatera, a ctDNA blood test for molecular residual disease assessment and surveillance of disease recurrence in patients previously diagnosed with cancer; Altera, a tissue based comprehensive genomic profiling test; Prospera to assess active rejection in patients who have undergone kidney transplantation; and Renasight, a kidney gene panel test. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was founded in 2003 and is headquartered in Austin, Texas."

Keywords

Are looking for the most relevant information about Natera? Investor spend a lot of time searching for information to make investment decisions in Natera. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Natera are: Natera, Price, Day, High, Week, Low, global, and the most common words in the summary are: natera, test, genetic, noninvasive, prenatal, usd, market, . One of the sentences in the summary was: Natera, Inc.: NASDAQ:NTRA Last Price 69.76 Change -0.92% Day High 70.96 52 Week High 71.29 Day Low 69.14 52 Week Low 36.90 Todays Open 70.41 Previous Close 70.42.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #natera #test #genetic #noninvasive #prenatal #usd #market.

Read more →

Youtube Subscribe

---